Aurinia Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AUPH Nasdaq 2834 www.auriniapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals and Four More Stocks See Activist Action - Jun 12th, 2026 4:47 pm
A Fresh Look At Aurinia Pharmaceuticals (AUPH) Valuation After Recent Share Price Consolidation - Jun 11th, 2026 8:11 am
Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million - Jun 7th, 2026 6:17 am
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death - Jun 4th, 2026 5:00 am
TANG CAPITAL MANAGEMENT, LLC FILES EARLY WARNING REPORT RESPECTING AURINIA PHARMACEUTICALS INC. - Jun 2nd, 2026 10:43 pm
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences - May 19th, 2026 6:30 am
We Believe Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings Are A Poor Guide For Its Profitability - May 15th, 2026 4:38 am
Aurinia Pharmaceuticals Inc. Just Beat EPS By 28%: Here's What Analysts Think Will Happen Next - May 9th, 2026 7:23 am
Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates - May 7th, 2026 9:15 am
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress - May 7th, 2026 6:00 am
ARS Pharmaceuticals, Inc. (SPRY) Soars 7.1%: Is Further Upside Left in the Stock? - Apr 23rd, 2026 6:41 am
United rises on IPF results; Biogen scores positive lupus data and an approval - Mar 30th, 2026 9:00 am
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Mar 30th, 2026 6:00 am
Does Aurinia’s Tang‑Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)? - Mar 29th, 2026 12:03 am
Mutiny At Aurinia Pharmaceuticals? Biotech Rallies On C-Suite Shake-Up - Mar 23rd, 2026 2:05 pm
MKT Capital Applauds Aurinia Pharmaceuticals’ Management Transition - Mar 23rd, 2026 9:00 am
Aurinia Announces Management Transition - Mar 23rd, 2026 6:00 am
Evommune Stock Sees RS Rating Rise To 91 - Mar 18th, 2026 11:11 am
Is Aurinia Pharmaceuticals (AUPH) Pricing Reflect Long Term Value After 71% One Year Gain - Mar 15th, 2026 4:08 pm
KalVista Pharmaceuticals Stock Sees RS Rating Jump To 86 - Mar 11th, 2026 12:36 pm